Invention Grant
- Patent Title: Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
-
Application No.: US15537619Application Date: 2015-12-18
-
Publication No.: US10202387B2Publication Date: 2019-02-12
- Inventor: Laurence Anne Mevellec , Lieven Meerpoel , Sophie Coupa , Virginie Sophie Poncelet , Isabelle Noelle Constance Pilatte , Elisabeth Therese Jeanne Pasquier , Didier Jean-Claude Berthelot , Olivier Alexis Georges Querolle , Christophe Meyer , Patrick Rene Angibaud , Christophe Gabriel Marcel Demestre , Guillaume Jean Maurice Mercey
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Priority: EP14199344 20141219
- International Application: PCT/EP2015/080623 WO 20151218
- International Announcement: WO2016/097359 WO 20160623
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D487/04 ; C07D405/10 ; C07B59/00 ; C07D519/00
Abstract:
The present invention relates to heterocyclyl linked imidazopyridazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as PI3Kβ inhibitors. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
Public/Granted literature
- US20180057496A1 HETEROCYCLYL LINKED IMIDAZOPYRIDAZINE DERIVATIVES AS PI3KB INHIBITORS Public/Granted day:2018-03-01
Information query
IPC分类:
